Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats

Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
Ozempic, Wegovy maker responds to Hims & Hers Super Bowl ad
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
What is compounded semaglutide and is it safe? The weight loss drugs Hims & Hers is selling, explained.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Hims & Hers Super Bowl Spot Draws Drug-Industry Backlash
Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto against weight-loss treatments priced “for profits, not patients,” after critici
Hims’ Super Bowl spot for compounded GLP-1 drugs draws Senate scrutiny
The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded drugs — not be false or misleading,” contended Pharmaceutical Research and Manufacturers of America (PhRMA), whose public affairs team invited reporters to “reach out if you have any questions.”
Hims & Hers Stock (HIMS) Falters on Backlash Over Super Bowl Ad
Telehealth company Hims & Hers Health (HIMS) recently stirred up controversy with its ad promoting its compounded weight-loss drugs aired
Hims & Hers Stock Bounces After Super Bowl Ad
Shares of Hims & Hers rose 5.2% Monday after the telehealth provider ran an advertisement on Super Bowl Sunday highlighting the company's efforts to fight the obesity epidemic in America. But Heard on
Hims & Hers Set To Run Impactful Super Bowl Ad
Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss offerings in a way that will generate buzz.
Drug industry groups target Hims & Hers Super Bowl ad touting weight loss drug
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
What the Hims Super Bowl Ad Is Really Selling
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be tweaked and optimized—as if it were peddling operating-system updates for the human body.
Hims & Hers Super Bowl ad sparks controversy
CNBC's Brandon Gomez joins 'Squawk on the Street' to break down the controversy around Hims & Hers Super Bowl ads.
Hims & Hers Health: Meme Potential Could Propel Explosive Growth
Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...
Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading' patients
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
GLP-1 ad battle—Ozempic and Wegovy maker responds to Hims & Hers Super Bowl debut
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
SF-based company airs controversial Super Bowl ad despite multiple objections
Hims & Hers, a San Francisco-headquartered telehealth company, ran its controversial Super Bowl commercial despite multiple ...
ConsumerAffairs11h
Super Bowl ad triggers sharp response from health groups
An ad during Sunday night’s Super Bowl has sparked instant controversy. Hims and Hers Health aired a commercial that not only promoted a product but fired ...
Daily Mail10h
Fury over 'most anti-America' Super Bowl 2025 ad as viewers blast company behind it
Hims and Hers has been slammed for its controversial Super Bowl commercial that admonished Americans for being obese and shamed the healthcare industry - then promoted its own weight loss drugs. The ...